Hannes Reichl - Compugroup Medical MD Board
| COP Stock | EUR 15.04 1.02 7.28% |
Insider
Hannes Reichl is MD Board of Compugroup Medical SE
| Age | 47 |
| Phone | 49 261 8000 0 |
| Web | https://www.cgm.com |
Compugroup Medical Management Efficiency
The company has return on total asset (ROA) of 0.033 % which means that it generated a profit of $0.033 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1153 %, meaning that it generated $0.1153 on every $100 dollars invested by stockholders. Compugroup Medical's management efficiency ratios could be used to measure how well Compugroup Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| JeanJacques Henchoz | Talanx AG | 59 | |
| Robert Smith | NMI Holdings | 53 | |
| Justin Scarpulla | Identiv | 50 | |
| Harry Kanwar | Superior Plus Corp | N/A | |
| Leigh Dow | Identiv | N/A | |
| James Devens | Superior Plus Corp | N/A | |
| Kali Beyah | Evolent Health | N/A | |
| Amir Khoshniyati | Identiv | N/A | |
| Torsten Leue | Talanx AG | 57 | |
| Jonathan JD | Evolent Health | 55 | |
| Caroline Schlienkamp | Talanx AG | 49 | |
| Rick Carron | Superior Plus Corp | N/A | |
| Bjorn Norrbom | SIVERS SEMICONDUCTORS AB | 72 | |
| Sven Pettersson | SIVERS SEMICONDUCTORS AB | 60 | |
| CCLP CMA | Superior Plus Corp | 62 | |
| Wilm Langenbach | Talanx AG | 52 | |
| Erik Wiklund | SIVERS SEMICONDUCTORS AB | 49 | |
| Steven Humphreys | Identiv | 62 | |
| Jessica Somers | Evolent Health | N/A | |
| Norman Fitzgerald | NMI Holdings | 56 | |
| FCA FCA | Superior Plus Corp | 68 | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 |
Compugroup Medical Leadership Team
Elected by the shareholders, the Compugroup Medical's board of directors comprises two types of representatives: Compugroup Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Compugroup. The board's role is to monitor Compugroup Medical's management team and ensure that shareholders' interests are well served. Compugroup Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Compugroup Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Helge Wei, VP Connectivity | ||
| Angela Teufer, Connectivity DACH | ||
| Hannes Reichl, MD Board | ||
| Alexander Weimer, Head Communications | ||
| Michael Franz, Co Communication | ||
| Oliver Bruzek, Chief Affairs | ||
| MBA LLM, MD CFO | ||
| Claudia Thom, Co Relations | ||
| Eckart Pech, MD Board | ||
| Emanuele Mugnani, MD Board |
Compugroup Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Compugroup Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.74 B | |||
| Shares Outstanding | 52.23 M | |||
| Shares Owned By Insiders | 50.30 % | |||
| Shares Owned By Institutions | 29.81 % | |||
| Price To Earning | 35.30 X | |||
| Price To Book | 2.99 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Compugroup Stock
Compugroup Medical financial ratios help investors to determine whether Compugroup Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Compugroup with respect to the benefits of owning Compugroup Medical security.